SE0302253D0 - Lipase-colipase inhibitor - Google Patents

Lipase-colipase inhibitor

Info

Publication number
SE0302253D0
SE0302253D0 SE0302253A SE0302253A SE0302253D0 SE 0302253 D0 SE0302253 D0 SE 0302253D0 SE 0302253 A SE0302253 A SE 0302253A SE 0302253 A SE0302253 A SE 0302253A SE 0302253 D0 SE0302253 D0 SE 0302253D0
Authority
SE
Sweden
Prior art keywords
colipase
lipase
inhibitor
obesity
prophylaxis
Prior art date
Application number
SE0302253A
Other languages
English (en)
Swedish (sv)
Inventor
Charlotte Erlanson-Albertsson
Original Assignee
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab filed Critical Forskarpatent I Syd Ab
Priority to SE0302253A priority Critical patent/SE0302253D0/xx
Publication of SE0302253D0 publication Critical patent/SE0302253D0/xx
Priority to JP2006523812A priority patent/JP2007502811A/ja
Priority to EP04775323A priority patent/EP1660062B1/de
Priority to PCT/SE2004/001216 priority patent/WO2005018625A1/en
Priority to AU2004266561A priority patent/AU2004266561A1/en
Priority to CA002536422A priority patent/CA2536422A1/en
Priority to DE602004014941T priority patent/DE602004014941D1/de
Priority to AT04775323T priority patent/ATE400259T1/de
Priority to DK04775323T priority patent/DK1660062T3/da
Priority to US11/358,772 priority patent/US7425577B2/en
Priority to US11/769,299 priority patent/US20080227865A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0302253A 2003-08-21 2003-08-21 Lipase-colipase inhibitor SE0302253D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0302253A SE0302253D0 (sv) 2003-08-21 2003-08-21 Lipase-colipase inhibitor
DK04775323T DK1660062T3 (da) 2003-08-21 2004-08-19 Anvendelse af colipase-lipase-inhibitorer til fremstilling af en farmaceutisk sammensætning med henblik på at forebygge obesitet
AU2004266561A AU2004266561A1 (en) 2003-08-21 2004-08-19 Use of colipase-lipase inhibitors in the preparation of a pharmaceutical composition in order to prevent obesity
EP04775323A EP1660062B1 (de) 2003-08-21 2004-08-19 Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas
PCT/SE2004/001216 WO2005018625A1 (en) 2003-08-21 2004-08-19 Use of colipase-lipase inhibitors in the preparation of a pharmaceutical composition in order to prevent obesity
JP2006523812A JP2007502811A (ja) 2003-08-21 2004-08-19 肥満の予防用の医薬組成物の製剤におけるコリパーゼ−リパーゼ阻害剤の使用
CA002536422A CA2536422A1 (en) 2003-08-21 2004-08-19 Use of colipase-lipase inhibitors in the preparation of a pharmaceutical composition in order to prevent obesity
DE602004014941T DE602004014941D1 (de) 2003-08-21 2004-08-19 Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas
AT04775323T ATE400259T1 (de) 2003-08-21 2004-08-19 Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas
US11/358,772 US7425577B2 (en) 2003-08-21 2006-02-21 Lipase-colipase inhibitor
US11/769,299 US20080227865A1 (en) 2003-08-21 2007-06-27 Colipse-lipase inhibitors in the preparation of a pharmaceutical composition in order to prevent obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302253A SE0302253D0 (sv) 2003-08-21 2003-08-21 Lipase-colipase inhibitor

Publications (1)

Publication Number Publication Date
SE0302253D0 true SE0302253D0 (sv) 2003-08-21

Family

ID=28450267

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302253A SE0302253D0 (sv) 2003-08-21 2003-08-21 Lipase-colipase inhibitor

Country Status (10)

Country Link
US (2) US7425577B2 (de)
EP (1) EP1660062B1 (de)
JP (1) JP2007502811A (de)
AT (1) ATE400259T1 (de)
AU (1) AU2004266561A1 (de)
CA (1) CA2536422A1 (de)
DE (1) DE602004014941D1 (de)
DK (1) DK1660062T3 (de)
SE (1) SE0302253D0 (de)
WO (1) WO2005018625A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040197321A1 (en) * 2002-03-19 2004-10-07 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
US20100021505A1 (en) * 2008-07-28 2010-01-28 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4816161B1 (de) * 1970-06-30 1973-05-19
US3896158A (en) * 1972-04-05 1975-07-22 Minnesota Mining & Mfg N,n-dialkylalkanolamines
GB1471431A (en) * 1974-04-30 1977-04-27 Science Union & Cie Alkanolamine derivatives processes for their preparation and pharmaceutical compositions containing them
US4062764A (en) * 1976-07-28 1977-12-13 Nalco Chemical Company Method for neutralizing acidic components in petroleum refining units using an alkoxyalkylamine
US4490455A (en) * 1982-12-20 1984-12-25 Xerox Corporation Amine acid salt charge enhancing toner additives
US4588843A (en) * 1984-04-26 1986-05-13 Ethyl Corporation Synthesis of (alkoxyalkyl) amines
DK583687A (da) * 1986-11-20 1988-05-21 Draco Ab Middel til regulering af appetit eller sovemiddel
JPH06172310A (ja) * 1990-03-20 1994-06-21 Banyu Pharmaceut Co Ltd 抗高脂血症作用を有する置換アミン誘導体
FR2758143B1 (fr) * 1997-01-07 1999-02-19 Laphal Laboratoire De Pharmaco Inhibiteurs specifiques de la lipase pancreatique et leurs applications
CA2318417A1 (en) * 1998-01-09 1999-07-15 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6521266B1 (en) * 1999-09-23 2003-02-18 Morris A. Mann Composition for growth hormone production and release, appetite suppression, and methods related thereto

Also Published As

Publication number Publication date
DE602004014941D1 (de) 2008-08-21
EP1660062B1 (de) 2008-07-09
US7425577B2 (en) 2008-09-16
US20080227865A1 (en) 2008-09-18
ATE400259T1 (de) 2008-07-15
JP2007502811A (ja) 2007-02-15
CA2536422A1 (en) 2005-03-03
DK1660062T3 (da) 2008-11-10
EP1660062A1 (de) 2006-05-31
AU2004266561A1 (en) 2005-03-03
WO2005018625A1 (en) 2005-03-03
US20060199869A1 (en) 2006-09-07

Similar Documents

Publication Publication Date Title
NO20052888L (no) Diamintriazoler anvendelige som inhibitorer av proteinkinaser
NO20072567L (no) Triazoler nyttige som proteinkinase-inhibitorer
NO20091864L (no) Forbindelser for inhibering av mitotisk progresjon
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
ATE530540T1 (de) Pyrimidonverbindungen als gsk-3-inhibitoren
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
NO20064852L (no) Azaindoler som er nyttige som inhibitorer av jak og andre proteinkinaser
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
ATE484508T1 (de) Furylverbindungen
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
WO2003099266A3 (en) Acetamides and benzamides that are useful in treating sexual dysfunction
EA200700601A1 (ru) Производные фениламинопиримидина как ингибиторы bcr-abl
DE60323765D1 (de) Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
PL376324A1 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
DE602008005786D1 (de) C-met-proteinkinasehemmer
ATE443044T1 (de) Tace inhibitoren
EA200800374A1 (ru) 1,4-дигидропиридин-конденсированные гетероциклы, способы их получения, применение и содержащие их композиции
ATE476982T1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
EA200600100A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
TW200503722A (en) Substituted 7-aza-quinazoline compounds
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
SE0302253D0 (sv) Lipase-colipase inhibitor
MX2009012079A (es) Compuestos heterociclicos condensados como inhibidores de proteina cinasas.